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Background
• ER visits for AIS grown in 
last 10 years by 25%
• Ongoing effort by AHA/ASA 
to improve access to care 
with early stroke recognition 
and awareness
• Time is brain; rate of 
thrombolysis with alteplase 
(ALT) should increase with 
better EMS systems, 
awareness, and education
Where to Improve?
• As rates of stroke alerts 
increase, the rate of ALT in 
the TJUH ER has remained 
the same
• What are the biases, 




Analysis of N=1901 (2015-20) above
Subset analysis (Jan & June, N=323)
Presentation/Demographics
Half (50%) presented w/in 4.5 hour time 
window (27% of them received ALT)
Stat sig trends: ALT given to older patients 
with higher NIHSS, higher BP
Not sig: Gender, race, language, time/day of 
presentation, method of arrival (EMS or self), 
PGY year, staffing fellow/attending
Outcomes
Of those receiving ALT, 67% had AIS 
diagnosis at discharge
MC non-AIS diagnosis: encephalopathy 
(15%), TIA (12%), recrudescence (11%), 
migraine (10%)
Take Home Points
• Biases – we avoided 
most demographic biases and 
confirmed clinical factors
• Factors – clinical decision 
making is key; neurology 
involvement is crucial
• Barriers – further 
education needed in ER to 
recognize stroke mimics
Next Steps:
• Finalize secondary analysis
• Discuss need for re-education 
in interdisciplinary stroke 
committee meeting
• Changes with tenecteplase
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Stroke Alerts and Rates of Alteplase 
Administration from 2015-2020
Most Common Documented
Reasons for Why ALT Not Given
"low suspicion for stroke" 32%
"low NIHSS score" 23%
"on anticoagulation" 16%
